Against the backdrop of a Cas9 patent battle that refuses to die, Editas Medicine is cashing in a chunk of the licensing rights from Vertex Pharmaceuticals to the tune of $57 million. Last last ...

Sept 26 (Reuters) - Pfizer's (PFE.N), opens new tab decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental ...

A VAMPIRE tomb has been unearthed with a sickle around its neck to prevent the "monster" from ever rising. The tomb was discovered by archaeologists deep beneath a church in northern Poland after ...

Conducted as part of the Sickle Cell Disease Implementation Consortium (SCDIC), the study included 2,282 individuals ages 15–45 years, with sickle cell disease. About 500 (22%) had HbSC.

On Wednesday, Pfizer Inc. (NYSE:PFE) said the company is voluntarily withdrawing all lots of Oxbryta (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all markets where ...

(Bloomberg) -- European regulators suspended the approval of Pfizer Inc.’s sickle cell anemia drug, Oxbryta, citing a higher rate of disease complications in patients who started taking it.

Pfizer’s decision Wednesday to pull its sickle cell pill off the market because of safety concerns shocked advocates and doctors, leaving many searching for answers and scrambling for ways to ...

Have a great day, everyone. … Pfizer is removing Oxbryta, a pill for the treatment of sickle cell disease, from all markets globally due to high risks of severe safety events, including deaths ...

The company is discontinuing all active trials of the sickle cell disease treatment, voxelotor, globally. Credit: Sebastian Kaulitzki/Shutterstock. Pfizer has announced the voluntary withdrawal of all ...

Sickle cell disease is an inherited condition that affects the oxygen-carrying hemoglobin protein in red blood cells. It carries a risk of a sickle cell crisis, pain, infections, and blood clots. The ...

Sickle cell crisis is a health complication of sickle cell disease, an inherited blood disorder. It usually causes severe pain, and it happens due to an acute blood cell reaction. Sometimes sickle ...

Pfizer (NYSE:PFE) has voluntarily withdrawn all lots of its sickle cell disease drug Oxbryta, also known as voxelotor, over safety concerns. The pharmaceutical giant said Oxbryta will be withdrawn ...